Completed
Efficacy and Safety of Valsartan Versus Placebo on Exercise Tolerance in Patients With Heart Failure
NCT00171106
- Conditions
- Cardiovascular Diseases, Diastolic Dysfunction, Symptomatic Heart Failure, Heart Diseases, +1 more
- Locations
-
- Investigative Centers, Germany
- Novartis Pharmaceuticals Basel, Switzerland